Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John S Partilla

Showing results (31-40 of 63) with videos related to

Pageof 7
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|February 7, 2009
Evidence for the involvement of dopamine transporters in behavioral stimulant effects of modafinilDorota Zolkowska, Raka Jain, Richard B Rothman, et al.
Experimental and Clinical Psychopharmacology|May 7, 2014
Abuse-related effects of dual dopamine/serotonin releasers with varying potency to release norepinephrine in male rats and rhesus monkeysMatthew L Banks, Clayton T Bauer, Bruce E Blough, et al.
Synapse (New York, N.Y.)|December 8, 2006
A comparison of noninternalizing (herkinorin) and internalizing (DAMGO) mu-opioid agonists on cellular markers related to opioid tolerance and dependenceHeng Xu, John S Partilla, Xiaoying Wang, et al.
European Journal of Pharmacology|November 15, 2011
Effects of MDMA and related analogs on plasma 5-HT: relevance to 5-HT transporters in blood and brainSamanta Yubero-Lahoz, Mario A Ayestas, Bruce E Blough, et al.
Psychopharmacology|October 23, 2018
The synthetic cathinones, butylone and pentylone, are stimulants that act as dopamine transporter blockers but 5-HT transporter substratesKusumika Saha, Yang Li, Marion Holy, et al.
European Journal of Pharmacology|November 27, 2012
Pharmacological examination of trifluoromethyl ring-substituted methcathinone analogsNicholas V Cozzi, Simon D Brandt, Paul F Daley, et al.
Journal of Medicinal Chemistry|September 6, 2002
Piperidine analogues of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine (GBR 12909): high affinity ligands for the dopamine transporterThomas Prisinzano, Elisabeth Greiner, Edward M Johnson, et al.
ACS Chemical Neuroscience|September 29, 2012
Binding of the amphetamine-like 1-phenyl-piperazine to monoamine transportersKasper Severinsen, Johan F Kraft, Heidi Koldsø, et al.
Journal of Medicinal Chemistry|April 4, 2003
Structure-activity relationship studies of highly selective inhibitors of the dopamine transporter: N-benzylpiperidine analogues of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazineElisabeth Greiner, Thomas Prisinzano, Edward M Johnson, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 25, 2006
Salvinorin A: allosteric interactions at the mu-opioid receptorRichard B Rothman, Daniel L Murphy, Heng Xu, et al.
Pageof 7

Showing results (31-40 of 63) with videos related to

Sort By:
Pageof 7
The Journal of Pharmacology and Experimental Therapeutics|February 7, 2009
Evidence for the involvement of dopamine transporters in behavioral stimulant effects of modafinilDorota Zolkowska, Raka Jain, Richard B Rothman, et al.
Experimental and Clinical Psychopharmacology|May 7, 2014
Abuse-related effects of dual dopamine/serotonin releasers with varying potency to release norepinephrine in male rats and rhesus monkeysMatthew L Banks, Clayton T Bauer, Bruce E Blough, et al.
Synapse (New York, N.Y.)|December 8, 2006
A comparison of noninternalizing (herkinorin) and internalizing (DAMGO) mu-opioid agonists on cellular markers related to opioid tolerance and dependenceHeng Xu, John S Partilla, Xiaoying Wang, et al.
European Journal of Pharmacology|November 15, 2011
Effects of MDMA and related analogs on plasma 5-HT: relevance to 5-HT transporters in blood and brainSamanta Yubero-Lahoz, Mario A Ayestas, Bruce E Blough, et al.
Psychopharmacology|October 23, 2018
The synthetic cathinones, butylone and pentylone, are stimulants that act as dopamine transporter blockers but 5-HT transporter substratesKusumika Saha, Yang Li, Marion Holy, et al.
European Journal of Pharmacology|November 27, 2012
Pharmacological examination of trifluoromethyl ring-substituted methcathinone analogsNicholas V Cozzi, Simon D Brandt, Paul F Daley, et al.
Journal of Medicinal Chemistry|September 6, 2002
Piperidine analogues of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine (GBR 12909): high affinity ligands for the dopamine transporterThomas Prisinzano, Elisabeth Greiner, Edward M Johnson, et al.
ACS Chemical Neuroscience|September 29, 2012
Binding of the amphetamine-like 1-phenyl-piperazine to monoamine transportersKasper Severinsen, Johan F Kraft, Heidi Koldsø, et al.
Journal of Medicinal Chemistry|April 4, 2003
Structure-activity relationship studies of highly selective inhibitors of the dopamine transporter: N-benzylpiperidine analogues of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazineElisabeth Greiner, Thomas Prisinzano, Edward M Johnson, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 25, 2006
Salvinorin A: allosteric interactions at the mu-opioid receptorRichard B Rothman, Daniel L Murphy, Heng Xu, et al.
Pageof 7